Athira Pharma, Inc. (ATHA) SEC filings
ATHA SEC filings moved a median of -0.91% by the close. ATHA SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the ATHA overview →
62 measured ATHA SEC filing events.
Where these ATHA SEC filings landedvs 44 measured ATHA SEC filing reactions
| Middle 50% of ATHA SEC filing reactions | -5.58% to +1.31% |
|---|---|
| Median reaction (to close) | -0.91% |
| Measured reactions | 44 |
Point-in-time · zero look-ahead
Half of the 44 ATHA SEC filing events with a measured close landed between -5.58% and +1.31%; 39% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K LeonaBio, Inc. For: Jun 22 | SEC filing · Form 8-K | — | — | |
| Form ARS LeonaBio, Inc. For: Dec 31 | SEC filing · Form ARS | — | — | |
| Form DEF 14A LeonaBio, Inc. For: Jun 22 | SEC filing · Form DEF | — | — | |
| Form DEFA14A LeonaBio, Inc. | SEC filing · Form DEFA14A | — | — | |
| Form 10-Q LeonaBio, Inc. For: Mar 31 | SEC filing · Form 10-Q | — | — | |
| Form 8-K LeonaBio, Inc. For: May 07 | SEC filing · Form 8-K | — | — | |
| Form EFFECT LeonaBio, Inc. | SEC filing · Form EFFECT | — | — | |
| Form S-8 LeonaBio, Inc. | SEC filing · Form S-8 | — | — | |
| Form 10-K LeonaBio, Inc. For: Dec 31 | SEC filing · Form 10-K | — | — | |
| Form 8-K/A LeonaBio, Inc. For: Dec 18 | SEC filing · Form 8-K | — | — | |
| Form S-1/A LeonaBio, Inc. | SEC filing · Form S-1 | — | — | |
| Form 8-K LeonaBio, Inc. For: Mar 26 | SEC filing · Form 8-K | — | — | |
| Form 8-K LeonaBio, Inc. For: Mar 18 | SEC filing · Form 8-K | — | — | |
| Form DEFR14A LeonaBio, Inc. | SEC filing · Form DEFR14A | — | — | |
| Form DEF 14A LeonaBio, Inc. For: Mar 18 | SEC filing · Form DEF | — | — | |
| Form PRE 14A LeonaBio, Inc. For: Mar 18 | SEC filing · Form PRE | — | — | |
| Form S-3 LeonaBio, Inc. | SEC filing · Form S-3 | — | — | |
| Form 8-K LeonaBio, Inc. For: Jan 07 | SEC filing · Form 8-K | — | — | |
| Form 8-K Athira Pharma, Inc. For: Dec 18 | SEC filing · Form 8-K | +6.22% | -7.05% | |
| Form 8-K/A Athira Pharma, Inc. For: Dec 18 | SEC filing · Form 8-K | +6.22% | -7.05% | |
| Form 10-Q Athira Pharma, Inc. For: Sep 30 | SEC filing · Form 10-Q | -1.52% | -2.53% | |
| Form 8-K Athira Pharma, Inc. For: Nov 06 | SEC filing · Form 8-K | -1.52% | -2.53% | |
| Form 8-K Athira Pharma, Inc. For: Oct 02 | SEC filing · Form 8-K | — | -0.48% | |
| Form 8-K Athira Pharma, Inc. For: Sep 10 | SEC filing · Form 8-K | +5.38% | +6.43% | |
| Form 10-Q Athira Pharma, Inc. For: Jun 30 | SEC filing · Form 10-Q | +1.77% | +1.82% | |
| Form 8-K Athira Pharma, Inc. For: Aug 07 | SEC filing · Form 8-K | +1.77% | +1.82% | |
| Form 8-K Athira Pharma, Inc. For: May 29 | SEC filing · Form 8-K | -1.86% | +7.96% | |
| Form 10-Q Athira Pharma, Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.04% | -5.92% | |
| Form 8-K Athira Pharma, Inc. For: May 09 | SEC filing · Form 8-K | +0.04% | -5.92% | |
| Form 8-K Athira Pharma, Inc. For: Apr 15 | SEC filing · Form 8-K | -0.55% | +1.14% | |
| Form ARS Athira Pharma, Inc. For: Dec 31 | SEC filing · Form ARS | +1.39% | -5.58% | |
| Form DEF 14A Athira Pharma, Inc. For: May 29 | SEC filing · Form DEF | +1.39% | -5.58% | |
| Form DEFA14A Athira Pharma, Inc. | SEC filing · Form DEFA14A | +1.39% | -5.58% | |
| Form PRE 14A Athira Pharma, Inc. For: May 29 | SEC filing · Form PRE | -11.53% | -0.48% | |
| Form 10-K Athira Pharma, Inc. For: Dec 31 | SEC filing · Form 10-K | -0.02% | +0.15% | |
| Form 8-K Athira Pharma, Inc. For: Feb 27 | SEC filing · Form 8-K | -0.02% | +0.15% | |
| Form S-8 Athira Pharma, Inc. | SEC filing · Form S-8 | -0.02% | +0.15% | |
| Form 10-Q Athira Pharma, Inc. For: Sep 30 | SEC filing · Form 10-Q | -4.29% | -7.71% | |
| Form 8-K Athira Pharma, Inc. For: Nov 07 | SEC filing · Form 8-K | -4.29% | -7.71% | |
| Form EFFECT Athira Pharma, Inc. | SEC filing · Form EFFECT | +0.00% | +0.85% | |
| Form S-3 Athira Pharma, Inc. | SEC filing · Form S-3 | -3.42% | -5.75% | |
| Form 8-K Athira Pharma, Inc. For: Oct 16 | SEC filing · Form 8-K | -3.42% | -5.75% | |
| Form 8-K Athira Pharma, Inc. For: Oct 01 | SEC filing · Form 8-K | +0.00% | +0.67% | |
| Form 8-K Athira Pharma, Inc. For: Sep 15 | SEC filing · Form 8-K | +0.70% | -3.86% | |
| Form 8-K Athira Pharma, Inc. For: Sep 03 | SEC filing · Form 8-K | -9.27% | -12.79% | |
| Form 10-Q/A Athira Pharma, Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.00% | -1.99% | |
| Form 10-Q Athira Pharma, Inc. For: Jun 30 | SEC filing · Form 10-Q | +2.02% | -0.31% | |
| Form 8-K Athira Pharma, Inc. For: Aug 01 | SEC filing · Form 8-K | +2.02% | -0.31% | |
| Form 8-K Athira Pharma, Inc. For: May 23 | SEC filing · Form 8-K | +0.00% | -1.56% | |
| Form 8-K Athira Pharma, Inc. For: May 03 | SEC filing · Form 8-K | -0.79% | -0.40% | |
| Form 10-Q Athira Pharma, Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.00% | +15.81% | |
| Form 8-K Athira Pharma, Inc. For: May 15 | SEC filing · Form 8-K | +0.00% | +15.81% | |
| Form ARS Athira Pharma, Inc. For: Dec 31 | SEC filing · Form ARS | +0.62% | +3.70% | |
| Form DEF 14A Athira Pharma, Inc. For: May 23 | SEC filing · Form DEF | +0.62% | +3.70% | |
| Form DEFA14A Athira Pharma, Inc. | SEC filing · Form DEFA14A | +0.62% | +3.70% | |
| Form PRE 14A Athira Pharma, Inc. For: May 23 | SEC filing · Form PRE | -0.39% | +5.79% | |
| Form 10-K Athira Pharma, Inc. For: Dec 31 | SEC filing · Form 10-K | -1.25% | -1.75% | |
| Form 8-K Athira Pharma, Inc. For: Feb 21 | SEC filing · Form 8-K | -1.25% | -1.75% | |
| Form S-8 Athira Pharma, Inc. | SEC filing · Form S-8 | -1.25% | -1.75% | |
| Form 8-K Athira Pharma, Inc. For: Jan 04 | SEC filing · Form 8-K | -1.20% | +10.84% | |
| Form 10-Q Athira Pharma, Inc. For: Sep 30 | SEC filing · Form 10-Q | -5.99% | -1.33% | |
| Form 8-K Athira Pharma, Inc. For: Nov 09 | SEC filing · Form 8-K | -5.99% | -1.33% |
Keep exploring
More ATHA: earnings → · analyst actions → · ATHA overview →